Inovio Pharmaceuticals Inc
NASDAQ:INO
Income Statement
Earnings Waterfall
Inovio Pharmaceuticals Inc
Revenue
|
832k
USD
|
Operating Expenses
|
-134.3m
USD
|
Operating Income
|
-133.4m
USD
|
Other Expenses
|
-1.7m
USD
|
Net Income
|
-135.1m
USD
|
Income Statement
Inovio Pharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
13
N/A
|
14
+7%
|
17
+21%
|
10
-44%
|
10
+7%
|
13
+27%
|
15
+11%
|
37
+151%
|
41
+9%
|
44
+7%
|
44
+2%
|
33
-26%
|
35
+8%
|
38
+6%
|
52
+38%
|
42
-19%
|
42
+1%
|
33
-21%
|
37
+12%
|
37
-2%
|
30
-17%
|
32
+4%
|
7
-76%
|
6
-15%
|
4
-35%
|
3
-36%
|
3
+5%
|
2
-23%
|
7
+250%
|
6
-13%
|
6
N/A
|
7
+1%
|
2
-73%
|
2
-10%
|
2
+32%
|
11
+420%
|
10
-6%
|
10
-1%
|
10
-5%
|
1
-91%
|
1
-2%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(34)
|
(38)
|
(45)
|
(47)
|
(50)
|
(51)
|
(59)
|
(69)
|
(76)
|
(85)
|
(90)
|
(102)
|
(113)
|
(121)
|
(126)
|
(125)
|
(127)
|
(128)
|
(127)
|
(124)
|
(125)
|
(122)
|
(120)
|
(117)
|
(115)
|
(110)
|
(116)
|
(127)
|
(132)
|
(153)
|
(208)
|
(232)
|
(303)
|
(322)
|
(343)
|
(328)
|
(278)
|
(250)
|
(180)
|
(161)
|
(134)
|
|
Selling, General & Administrative |
(13)
|
(14)
|
(15)
|
(15)
|
(16)
|
(16)
|
(16)
|
(17)
|
(18)
|
(19)
|
(20)
|
(22)
|
(24)
|
(26)
|
(27)
|
(27)
|
(28)
|
(30)
|
(31)
|
(32)
|
(29)
|
(27)
|
(25)
|
(24)
|
(27)
|
(28)
|
(33)
|
(37)
|
(37)
|
(44)
|
(45)
|
(48)
|
(54)
|
(56)
|
(92)
|
(90)
|
(90)
|
(88)
|
(53)
|
(51)
|
(48)
|
|
Research & Development |
(21)
|
(24)
|
(30)
|
(31)
|
(34)
|
(35)
|
(42)
|
(51)
|
(58)
|
(67)
|
(70)
|
(80)
|
(89)
|
(95)
|
(99)
|
(98)
|
(99)
|
(99)
|
(97)
|
(94)
|
(95)
|
(95)
|
(95)
|
(92)
|
(88)
|
(83)
|
(83)
|
(90)
|
(94)
|
(114)
|
(163)
|
(183)
|
(249)
|
(266)
|
(252)
|
(238)
|
(188)
|
(162)
|
(127)
|
(110)
|
(87)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(21)
N/A
|
(24)
-14%
|
(28)
-17%
|
(37)
-33%
|
(40)
-7%
|
(38)
+4%
|
(44)
-16%
|
(32)
+28%
|
(35)
-11%
|
(41)
-17%
|
(45)
-10%
|
(69)
-53%
|
(77)
-11%
|
(84)
-8%
|
(74)
+11%
|
(83)
-12%
|
(85)
-2%
|
(94)
-12%
|
(90)
+5%
|
(87)
+3%
|
(94)
-8%
|
(90)
+4%
|
(113)
-26%
|
(110)
+2%
|
(111)
-1%
|
(108)
+3%
|
(113)
-5%
|
(125)
-11%
|
(124)
+1%
|
(147)
-18%
|
(201)
-37%
|
(225)
-12%
|
(301)
-34%
|
(320)
-6%
|
(341)
-7%
|
(317)
+7%
|
(268)
+16%
|
(240)
+10%
|
(171)
+29%
|
(160)
+6%
|
(133)
+17%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(47)
|
(46)
|
(41)
|
(8)
|
3
|
2
|
11
|
10
|
3
|
13
|
3
|
3
|
3
|
(6)
|
(5)
|
(10)
|
(5)
|
(1)
|
(2)
|
4
|
(1)
|
(4)
|
(4)
|
(6)
|
(10)
|
(17)
|
(114)
|
(52)
|
(43)
|
(37)
|
63
|
1
|
(2)
|
(6)
|
(11)
|
(12)
|
(6)
|
5
|
12
|
15
|
14
|
|
Non-Reccuring Items |
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
(1)
|
5
|
0
|
1
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(13)
|
(11)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
1
|
0
|
(0)
|
(0)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(4)
|
(6)
|
(8)
|
(7)
|
(5)
|
|
Pre-Tax Income |
(66)
N/A
|
(68)
-3%
|
(68)
+0%
|
(44)
+35%
|
(36)
+18%
|
(36)
+1%
|
(31)
+13%
|
(20)
+35%
|
(31)
-53%
|
(29)
+8%
|
(41)
-44%
|
(66)
-60%
|
(74)
-12%
|
(89)
-20%
|
(80)
+10%
|
(93)
-17%
|
(88)
+5%
|
(95)
-8%
|
(92)
+3%
|
(83)
+10%
|
(95)
-14%
|
(94)
+1%
|
(117)
-25%
|
(116)
+1%
|
(121)
-5%
|
(125)
-3%
|
(223)
-79%
|
(179)
+20%
|
(163)
+9%
|
(184)
-13%
|
(138)
+25%
|
(219)
-59%
|
(303)
-39%
|
(326)
-8%
|
(353)
-8%
|
(330)
+6%
|
(278)
+16%
|
(241)
+13%
|
(168)
+30%
|
(165)
+2%
|
(135)
+18%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(66)
|
(68)
|
(68)
|
(44)
|
(36)
|
(36)
|
(31)
|
(19)
|
(29)
|
(27)
|
(39)
|
(65)
|
(74)
|
(89)
|
(80)
|
(93)
|
(88)
|
(97)
|
(95)
|
(86)
|
(97)
|
(94)
|
(117)
|
(115)
|
(121)
|
(124)
|
(223)
|
(179)
|
(163)
|
(184)
|
(138)
|
(219)
|
(303)
|
(326)
|
(353)
|
(330)
|
(278)
|
(241)
|
(168)
|
(165)
|
(135)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Equity Earnings Affiliates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(3)
|
(5)
|
(5)
|
(4)
|
(2)
|
(0)
|
(2)
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(66)
N/A
|
(68)
-3%
|
(68)
+0%
|
(44)
+35%
|
(36)
+18%
|
(36)
+1%
|
(31)
+12%
|
(19)
+41%
|
(29)
-57%
|
(27)
+9%
|
(39)
-47%
|
(65)
-67%
|
(74)
-13%
|
(89)
-20%
|
(80)
+10%
|
(93)
-17%
|
(88)
+5%
|
(97)
-10%
|
(95)
+3%
|
(86)
+10%
|
(97)
-13%
|
(94)
+3%
|
(117)
-24%
|
(115)
+2%
|
(119)
-4%
|
(123)
-3%
|
(222)
-81%
|
(180)
+19%
|
(166)
+7%
|
(188)
-13%
|
(142)
+25%
|
(221)
-56%
|
(304)
-37%
|
(328)
-8%
|
(355)
-8%
|
(332)
+6%
|
(280)
+16%
|
(241)
+14%
|
(168)
+30%
|
(165)
+2%
|
(135)
+18%
|
|
EPS (Diluted) |
-1.26
N/A
|
-1.23
+2%
|
-1.12
+9%
|
-0.73
+35%
|
-0.61
+16%
|
-0.59
+3%
|
-0.46
+22%
|
-0.25
+46%
|
-0.43
-72%
|
-0.37
+14%
|
-0.54
-46%
|
-0.9
-67%
|
-1.01
-12%
|
-1.2
-19%
|
-1.07
+11%
|
-1.06
+1%
|
-1.08
-2%
|
-1.07
+1%
|
-1.03
+4%
|
-0.94
+9%
|
-1.05
-12%
|
-0.98
+7%
|
-1.18
-20%
|
-1.17
+1%
|
-1.21
-3%
|
-0.98
+19%
|
-1.42
-45%
|
-1.03
+27%
|
-1.07
-4%
|
-0.93
+13%
|
-0.69
+26%
|
-1.05
-52%
|
-1.45
-38%
|
-1.49
-3%
|
-1.5
-1%
|
-1.33
+11%
|
-1.17
+12%
|
-0.93
+21%
|
-0.63
+32%
|
-0.61
+3%
|
-6.09
-898%
|